{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:10:47Z","timestamp":1793146247425,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11060-026-05501-x","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:08:13Z","timestamp":1773122893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glioblastoma survival in rural America: a 10-year experience from a quaternary care center"],"prefix":"10.1007","volume":"177","author":[{"given":"Emily","family":"Pack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cifarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Brandmeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Gleckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng Cheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolan A.","family":"Wages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Shaun","family":"Dotson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan W.","family":"Denney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Armistead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonikpreet","family":"Aulakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"Suppl 4","key":"5501_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noae123","volume":"26","author":"QT Ostrom","year":"2024","unstructured":"Ostrom QT, Price M, Ryan K, Cioffi G, Kruchko C, Waite K et al (2024) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017\u20132021. Neuro Oncol 26(Suppl 4):iv1\u2013iv49. https:\/\/doi.org\/10.1093\/neuonc\/noae123","journal-title":"Neuro Oncol"},{"issue":"8","key":"5501_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5501_CR3","doi-asserted-by":"publisher","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma: conclusive results of a randomized phase III trial by the Sara Swann Foundation for Neuroscience and the European Organisation for Research and Treatment of Cancer Brain and Radiotherapy Groups. J Clin Oncol 23(16suppl):2. https:\/\/doi.org\/10.1200\/JCO.2005.23.16_suppl.2. (Full trial: Stupp R, Mason, WP, van den Bent MJ et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330)","DOI":"10.1200\/JCO.2005.23.16_suppl.2"},{"issue":"1","key":"5501_CR4","doi-asserted-by":"publisher","first-page":"vdad058","DOI":"10.1093\/noajnl\/vdad058","volume":"5","author":"N Lamba","year":"2023","unstructured":"Lamba N, Muskens IS, DiRisio AC, Broekman ML, Kruchko C, Waite KA et al (2023) Long-term survival in glioblastoma: a systematic review and meta-analysis of real-world evidence. Neurooncol Adv 5(1):vdad058. https:\/\/doi.org\/10.1093\/noajnl\/vdad058","journal-title":"Neurooncol Adv"},{"issue":"2","key":"5501_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11060-023-04289-5","volume":"162","author":"JS Barnholtz-Sloan","year":"2023","unstructured":"Barnholtz-Sloan JS, Ostrom QT, Shetty S, Williams VL, Wilson T, Johnson DR et al (2023) Comparative survival of patients with glioblastoma using real-world data from the US National Cancer Database (NCDB) and SEER program. J Neurooncol 162(2):345\u2013354. https:\/\/doi.org\/10.1007\/s11060-023-04289-5","journal-title":"J Neurooncol"},{"issue":"11","key":"5501_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2(11):1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"issue":"1","key":"5501_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11060-021-03957-0","volume":"158","author":"WE Zahnd","year":"2022","unstructured":"Zahnd WE, Murphy KM, Batai K, Wells K, Stratton MS, Maki CG et al (2022) Rural-urban differences in the receipt of adjuvant radiation therapy for high-grade gliomas: a population-based analysis. J Neurooncol 158(1):101\u2013111. https:\/\/doi.org\/10.1007\/s11060-021-03957-0","journal-title":"J Neurooncol"},{"issue":"3","key":"5501_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/jrh.12549","volume":"37","author":"F Chino","year":"2021","unstructured":"Chino F, Peppercorn J, Taylor E, Hall R, Neal B, Blackstock W et al (2021) Rural-urban differences in travel distance and treatment initiation time for patients with head and neck cancer in North Carolina. J Rural Health 37(3):609\u2013616. https:\/\/doi.org\/10.1111\/jrh.12549","journal-title":"J Rural Health"},{"issue":"5","key":"5501_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/OP.23.00721","volume":"20","author":"R Singh","year":"2024","unstructured":"Singh R, Devlin SM, Inman K, Armstrong A, Kimes S, Reeder-Hayes K et al (2024) Rural-urban disparities in cancer outcomes: a systematic review. JCO Oncol Pract 20(5):678\u2013688. https:\/\/doi.org\/10.1200\/OP.23.00721","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"5501_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/jrh.12413","volume":"36","author":"NJ Doogan","year":"2020","unstructured":"Doogan NJ, Roberts ME, Wewers ME et al (2020) The impact of rural residence on adult brain cancer survival in the United States. J Rural Health 36(4):456\u2013463. https:\/\/doi.org\/10.1111\/jrh.12413","journal-title":"J Rural Health"},{"issue":"1","key":"5501_CR11","doi-asserted-by":"publisher","first-page":"vdab094","DOI":"10.1093\/noajnl\/vdab094","volume":"3","author":"J Shen","year":"2021","unstructured":"Shen J, Shriver B, Tykocinski E, Taylor LP, Lin E, Wu X (2021) Rural-urban disparities in high-grade glioma survival: a systematic review and meta-analysis. Neurooncol Adv 3(1):vdab094. https:\/\/doi.org\/10.1093\/noajnl\/vdab094","journal-title":"Neurooncol Adv"},{"issue":"2","key":"5501_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11060-025-04567-8","volume":"173","author":"JT Butterfield","year":"2025","unstructured":"Butterfield JT, Golzarian R, Smith KA, Venteicher AS, Chen CC, Sherman JH (2025) Rural-urban survival disparities in glioblastoma are eliminated in patients treated at a comprehensive cancer center. J Neurooncol 173(2):285\u2013293. https:\/\/doi.org\/10.1007\/s11060-025-04567-8(Adapted from UVM Larner College of Medicine single-center analysis)","journal-title":"J Neurooncol"},{"key":"5501_CR13","unstructured":"U.S. Census Bureau. American Community Survey 1-year estimates: percent rural population by state (2023) Washington, DC: U.S. Department of Commerce; 2024. Available from: https:\/\/www.census.gov\/programs-surveys\/acs\/data.html"},{"key":"5501_CR14","unstructured":"United States Department of Agriculture Economic Research Service. Rural-Urban Commuting Area (RUCA) codes: documentation. Washington, DC: U.S. Department of Agriculture (2023) [cited 2025 Nov 16]. Available from: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes"},{"issue":"1","key":"5501_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1186\/s12913-025-12988-z","volume":"25","author":"G Sarriera Valentin","year":"2025","unstructured":"Sarriera Valentin G, D\u2019Agostino E, Callas P et al (2025) Single-center retrospective analysis of the impact of rurality on glioblastoma care in Vermont. BMC Health Serv Res 25(1):1052. https:\/\/doi.org\/10.1186\/s12913-025-12988-z","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"5501_CR16","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3171\/2023.8.FOCUS23509","volume":"55","author":"D Estevez-Ordonez","year":"2023","unstructured":"Estevez-Ordonez D, Abdelrashid M, Coffee E et al (2023) County-level disparities in care for patients with glioblastoma. Neurosurg Focus 55(5):E12. https:\/\/doi.org\/10.3171\/2023.8.FOCUS23509","journal-title":"Neurosurg Focus"},{"issue":"1","key":"5501_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nop\/npy031","volume":"6","author":"DR Johnson","year":"2019","unstructured":"Johnson DR, O\u2019Neill BP, Morris J et al (2019) Patterns and disparities of care in glioblastoma. Neurooncol Pract 6(1):37\u201346. https:\/\/doi.org\/10.1093\/nop\/npy031","journal-title":"Neurooncol Pract"},{"issue":"2","key":"5501_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3171\/2018.10.JNS182247","volume":"132","author":"P Zhu","year":"2019","unstructured":"Zhu P, Du XL, Zhu JJ, Esquenazi Y (2019) Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. J Neurosurg 132(2):491\u2013502. https:\/\/doi.org\/10.3171\/2018.10.JNS182247","journal-title":"J Neurosurg"},{"key":"5501_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jocn.2019.04.028","volume":"68","author":"S Aulakh","year":"2019","unstructured":"Aulakh S, DeDeo MR, Free J, Rosenfeld SS, Quinones-Hinojosa A, Paulus A et al (2019) Survival trends in glioblastoma and association with treating facility volume. J Clin Neurosci 68:271\u2013274. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.028","journal-title":"J Clin Neurosci"},{"issue":"3","key":"5501_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s11060-022-04227-w","volume":"161","author":"S Aulakh","year":"2023","unstructured":"Aulakh S, DeDeo MR, Free J et al (2023) Facility patient volume and survival among individuals diagnosed with malignant central nervous system tumors. J Neurooncol 161(3):535\u2013543. https:\/\/doi.org\/10.1007\/s11060-022-04227-w","journal-title":"J Neurooncol"},{"issue":"1","key":"5501_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4081\/oncol.2020.461","volume":"14","author":"E Alimohammadi","year":"2020","unstructured":"Alimohammadi E, Bagheri SR, Taheri S, Dayani M, Abdi A (2020) The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review. Oncol Rev 14(1):461. https:\/\/doi.org\/10.4081\/oncol.2020.461","journal-title":"Oncol Rev"},{"issue":"1","key":"5501_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12885-025-13757-1","volume":"25","author":"MAM Inggas","year":"2025","unstructured":"Inggas MAM, Patel U, Wijaya JH et al (2025) The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis. BMC Cancer 25(1):399. https:\/\/doi.org\/10.1186\/s12885-025-13757-1","journal-title":"BMC Cancer"},{"issue":"22","key":"5501_CR23","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.3390\/cancers13225770","volume":"13","author":"T Jayakrishnan","year":"2021","unstructured":"Jayakrishnan T, Patel A, Ganti AK (2021) Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting. Cancers (Basel) 13(22):5770. https:\/\/doi.org\/10.3390\/cancers13225770","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05501-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:36:52Z","timestamp":1776069412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05501-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5501"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05501-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the Declaration of Helsinki and approved by the West Virginia Uinversity Institutional Review Board, which waived the requirement for informed consent due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable (retrospective study).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}